tirzepatide updates Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ How Tirzepatide Supports Brain Health

It will not suppress appetite

The formula for turning a desired dose into the exact volume to draw, with worked examples

Understanding Medical Weight Loss Medical weight loss is not one-size-fits-all

The evidence is clear: GLP-1 receptor agonists produce clinically meaningful weight loss and metabolic improvements in people with obesity and type 2 diabetes

Those who use the appetite suppression time to establish healthy eating patterns maintain results better than those who simply rely on the compounds effects without behavioral change

Focus instead on lean proteins, non-starchy vegetables, and complex carbohydrates in appropriate portions